International Journal of Hematology

, Volume 73, Issue 3, pp 339–345 | Cite as

Increased Frequency of Monoclonal Gammopathy of Undetermined Significance in Patients With Nonimmune Chronic Idiopathic Neutropenia Syndrome

  • Helen A. Papadaki
  • Dimitris G. Eliopoulos
  • Charis Ponticoglou
  • George D. Eliopoulos
Rapid Communication


This study describes the frequency of monoclonal gammopathy of undetermined significance (MGUS) and the changes in some inflammation-related serum proteins in 157 patients with nonimmune chronic idiopathic neutropenia syndrome (NI-CINS). Of these patients, 42 had pronounced neutropenia with neutrophil counts < 1500/μL, and 115 had mild neutropenia with neutrophil counts ranging from 1500 to 2499/μL. Sixty-six volunteers served as healthy control subjects and 157 ageand sex-matched patients hospitalized for nonmalignant diseases served as patient control subjects. We found that 28.6% of patients with pronounced neutropenia and 14.8% of patients with mild neutropenia had increased serum gamma globulins (above the 95% confidence limit of values of the control subjects). In the group of patients with pronounced neutropenia, 30.9% had increased immunoglobulin (Ig)G values and 23.8% had increased IgA values. In the group of patients with mild neutropenia, 17.4% had increased IgG values and 21.7% had increased IgA values. IgG and IgA values strongly correlated with the neutrophil count. No changes in serum IgM were found. Three of 42 patients with pronounced neutropenia (7.14%) and 3 of 115 patients with mild neutropenia (2.61%) had serum immunofixation tests which showed a small monoclonal spike—4 were IgG-K type, 1 was IgG-γ type, and 1 was IgA-K type. None of the healthy or patient control subjects had any evidence of MGUS. No significant changes in the amount of monoclonal spikes were documented during an 18- to 143-month follow-up (median, 58 months). Except for significantly increased α1-antitrypsin levels, there were no significant differences in the levels of acute-phase proteins studied between the study patients and the control subjects. These findings are consistent with our previous report suggesting the possible existence of an unrecognized low-grade chronic inflammation in patients with NI-CINS, which may be involved in the pathogenesis of neutropenia in the affected subjects.

Key words

Nonimmune chronic idiopathic neutropenia syndrome Paraproteinemia M-component Serum immunoglobulins Serum acute-phase proteins 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kyle RA, Linman JW. Chronic idiopathic neutropenia.N Engl J Med. 1968;279:1015–1019.CrossRefPubMedGoogle Scholar
  2. 2.
    Dale D, Guerry D, Wewerka J, Bull J, Chusid M. Chronic neutropenia.Medicine (Baltimore). 1979;58:128–144.CrossRefGoogle Scholar
  3. 3.
    Papadaki HA, Xylouri I, Coulocheri S, Kalmanti M, Kafatos A, Eliopoulos GD. Prevalence of chronic idiopathic neutropenia of adults among an apparently healthy population living on the island of Crete.Ann Hematol. 1999;78:293–297.CrossRefPubMedGoogle Scholar
  4. 4.
    Haddy TB, Rana SR, Castro O. Benign ethnic neutropenia: what is a healthy absolute neutrophil count?J Lab Clin Med. 1999;133:15–22.CrossRefPubMedGoogle Scholar
  5. 5.
    Papadaki HA, Eliopoulos GD. Enhanced neutrophil extravasation may be a contributing factor in the determination of neutropenia in patients with chronic idiopathic neutropenia of adults.Eur J Haematol. 1998;61:272–277.CrossRefPubMedGoogle Scholar
  6. 6.
    Papadaki HA, Coulocheri S, Eliopoulos GD. Patients with chronic idiopathic neutropenia of adults have increased serum concentrations of inflammatory cytokines and chemokines.Am J Hematol. 2000;65:271–277.CrossRefPubMedGoogle Scholar
  7. 7.
    Papadaki HA, Eliopoulos GD. Selective loss of peripheral blood CD45RO+ T-lymphocytes correlates with increased levels of serum cytokines and endothelial cell-derived cell adhesion molecules in patients with chronic idiopathic neutropenia of adults.Ann Hematol. 1998;77:153–159.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Papadaki HA, Giouremou K, Eliopoulos GD. Low frequency of myeloid progenitor cells in chronic idiopathic neutropenia of adults may be related to increased production of TGF-β1 by bone marrow stromal cells.Eur J Haematol. 1999;63:154–162.CrossRefPubMedGoogle Scholar
  9. 9.
    Papadaki HA, Palmblad J, Kapsimali V, Anagnou NP, Eliopoulos GD. Increased serum IgA and decreased IgG3 strongly correlate with increased levels of serum TGF-β1 in patients with nonimmune chronic idiopathic neutropenia of adults.Eur J Haematol. 2000;65:237–244.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Papadaki HA, Chatzivassili A, Stefanaki K, Koumaki V, Kanavaros P, Eliopoulos GD. Morphologically defined myeloid cell compartments, lymphocyte subpopulations and histological findings of bone marrow in patients with nonimmune chronic idiopathic neutropenia of adults.Ann Hematol. 2000;79:563–570.CrossRefPubMedGoogle Scholar
  11. 11.
    Papadaki HA, Katrinakis G, Eliopoulos AG, Coulocheri SA, Alexandrakis M, Eliopoulos GD. Low numbers of peripheral blood natural killer cells in patients with chronic idiopathic neutropenia of adults is probably due to enhanced extravasation into the tissues.Haematologica. 1998;1:32–39.Google Scholar
  12. 12.
    Hoffbrand AV, Pettit JE.Essential Haematology. 3rd ed. Oxford, England: Blackwell Scientific Publications; 1993.Google Scholar
  13. 13.
    Islam KB, Baskin B, Nilsson L, Hammarstrom L, Sideras P, Smith CI. Molecular analysis of IgA deficiency: evidence for impaired switching to IgA.J Immunol. 1994;152:1442–1452.PubMedGoogle Scholar
  14. 14.
    Foerster J. Plasma cell dyscrasias. In: Lee GR, et al, eds.Wintrobe’s Clinical Hematology. Vol. 2. Philadelphia, PA: Lee & Febiger; 1993:2202–2218.Google Scholar
  15. 15.
    Kyle RA, Lust JA. Monoclonal gammopathies of undetermined significance.Semin Hematol. 1989;26:176–200.PubMedGoogle Scholar
  16. 16.
    Hallen J. Frequency of ‘abnormal’ serum globulins (M-components) in the aged.Acta Med Scand. 1963;173:737–744.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Fine JM, Lambin P, Leroux P. Frequency of monoclonal gammopathies (‘M-components’) in 13400 sera from blood donors.Vox Sang. 1972;23:336–343.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Fine JM, Lambin P, Derycke C, Muller JY, Marneux M. Systematic survey of monoclonal gammopathies in the sera from blood donors.Transfusion. 1979;19:332–335.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Cohen HJ. Monoclonal gammopathies and aging [abstract].Hosp Pract. 1988;23(3A):75.Google Scholar
  20. 20.
    Norgaard O. Three cases of multiple myeloma in which the preclinical asymptomatic phases persisted for 15 to 24 years.Br J Cancer. 1971;25:417–422.CrossRefPubMedGoogle Scholar
  21. 21.
    Hallek M, Bergsagel PL, Anderson KC. Multiple myeloma: increasing evidence for a multistep transformation process.Blood. 1998;91:3–21.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Axelsson U, Hallen J. Familial occurrence of pathological serum proteins of different gammaglobulin groups.Lancet. 1965;2:369–370.CrossRefPubMedGoogle Scholar
  23. 23.
    Radl J. Idiopathic paraproteinemia: a consequence of an agerelated deficiency in the T immune system.Clin Immunol Immunopathol. 1979;14:251–255.CrossRefPubMedGoogle Scholar
  24. 24.
    Pradella M, Nemetz L, Bovo C, et al. Quantitative cytochemistry of human leukocyte elastase compared with plasma elastase and acute phase proteins in inflammatory diseases.Clin Chim Acta. 1995;239:91–101.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2001

Authors and Affiliations

  • Helen A. Papadaki
    • 1
  • Dimitris G. Eliopoulos
    • 1
  • Charis Ponticoglou
    • 1
  • George D. Eliopoulos
    • 1
  1. 1.Department of HematologyUniversity of Crete School of Medicine, University Hospital of HeraklionCreteGreece

Personalised recommendations